These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10979391)

  • 21. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture.
    McGarry KA; Kiel DP
    Postgrad Med; 2000 Sep; 108(3):79-82, 85-8, 91. PubMed ID: 11004937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention, diagnosis, and management of osteoporosis-related fracture.
    Fakih M
    J Am Osteopath Assoc; 2009 Mar; 109(3):191-3. PubMed ID: 19336772
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.
    Miller E
    Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.
    Palomba S; Orio F; Russo T; Colao A; Lombardi G; Zullo F
    Fertil Steril; 2004 Feb; 81(2):476-8. PubMed ID: 14967398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing osteoporosis.
    Atkinson H
    Health News; 1998 Mar; 4(3):1-2. PubMed ID: 9516335
    [No Abstract]   [Full Text] [Related]  

  • 27. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 29. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM
    Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Who are the candidates for the treatment by raloxifen ?].
    Hagino H
    Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the prevention and treatment of postmenopausal osteoporosis.
    Shaefer MA
    Ohio Nurses Rev; 1999 Jan; 74(1):3, 5, 10-1 passim; quiz 15. PubMed ID: 10614426
    [No Abstract]   [Full Text] [Related]  

  • 34. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial.
    Black DM; Thompson DE
    Int J Clin Pract Suppl; 1999 Apr; 101():46-50. PubMed ID: 12669740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alendronic acid in primary prevention: new indication. No reduction in fracture risk.
    Prescrire Int; 2000 Jun; 9(47):70-2. PubMed ID: 11010741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].
    MMW Fortschr Med; 2005 Apr; 147(14):44. PubMed ID: 15887685
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E; Kalin MF
    Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG
    Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.